In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials. 

As lockdowns sweep the country and people prepare to work from home for months, many are wondering whether springtime’s warmer temperatures will provide much-needed relief from the coronavirus. Others, including President Donald Trump, have made the case that it’s a certainty.

Seattle’s Infectious Disease Research Institute has received seven-figure funding to begin human trials on a potentially groundbreaking novel coronavirus treatment.

The study could launch within weeks, take about 11 months to complete, and enroll about 100 patients diagnosed with a COVID-19 infection that’s causing moderate to severe pneumonia. It would deploy cancer-fighting NK-cells as an immunotherapy treatment for the coronavirus rather than the current approach of antiviral medication.

As the coronavirus spreads, Seattle and its suburbs have become America’s laboratory and guinea pig.

The response now touches every part of daily life. From restaurant closures to bans on gatherings to the total reorientation in the area's research centers, sweeping changes arrive at a pace unimaginable two weeks ago.